Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 199909

1.

Immunotherapy for Lymphangioleiomyomatosis and Tuberous Sclerosis: Progress and Future Directions.

Liu HJ, Krymskaya VP, Henske EP.

Chest. 2019 Aug 19. pii: S0012-3692(19)31461-8. doi: 10.1016/j.chest.2019.08.005. [Epub ahead of print]

PMID:
31437431
2.

Imaging challenges of immunotherapy and targeted therapy in patients with brain metastases: Response, Progression, and Pseudoprogression.

Galldiks N, Kocher M, Ceccon G, Werner JM, Brunn A, Deckert M, Pope WB, Soffietti R, Le Rhun E, Weller M, Tonn JC, Fink GR, Langen KJ.

Neuro Oncol. 2019 Aug 22. pii: noz147. doi: 10.1093/neuonc/noz147. [Epub ahead of print]

PMID:
31437274
3.

Binimetinib in heavily pretreated NRAS-mutant Melanoma Patients with Brain Metastases.

Goldinger SM, Valeska Matter A, Urner-Bloch U, Narainsing J, Micaletto S, Blume I, Mangana J, Dummer R.

Br J Dermatol. 2019 Aug 22. doi: 10.1111/bjd.18449. [Epub ahead of print]

PMID:
31436845
4.

Integrated treatment of brain metastases.

Rosenfelder N, Brada M.

Curr Opin Oncol. 2019 Aug 20. doi: 10.1097/CCO.0000000000000573. [Epub ahead of print]

PMID:
31436564
5.

Synergistic combination of chemo‑phototherapy based on temozolomide/ICG‑loaded iron oxide nanoparticles for brain cancer treatment.

Kwon YM, Je JY, Cha SH, Oh Y, Cho WH.

Oncol Rep. 2019 Aug 21. doi: 10.3892/or.2019.7289. [Epub ahead of print]

PMID:
31436296
6.

Interleukin 10 promotes growth and invasion of glioma cells by up-regulating KPNA 2 in vitro.

Zhang Z, Huang X, Li J, Fan H, Yang F, Zhang R, Yang Y, Feng S, He D, Sun W, Xin T.

J Cancer Res Ther. 2019;15(4):927-932. doi: 10.4103/jcrt.JCRT_284_19.

PMID:
31436254
7.

Computed tomography-magnetic resonance imaging fusion-guided iodine-125 seed implantation for single malignant brain tumor: Feasibility and safety.

Liu SF, Lu J, Wang H, Han Y, Wang DF, Yang LL, Li ZX, Hu XK.

J Cancer Res Ther. 2019;15(4):818-824. doi: 10.4103/jcrt.JCRT_70_19.

PMID:
31436237
8.

Age-dependent brain volume and neuropsychological changes after chemotherapy in breast cancer patients.

Blommaert J, Schroyen G, Vandenbulcke M, Radwan A, Smeets A, Peeters R, Sleurs C, Neven P, Wildiers H, Amant F, Sunaert S, Deprez S.

Hum Brain Mapp. 2019 Aug 21. doi: 10.1002/hbm.24753. [Epub ahead of print]

PMID:
31436005
9.

Role of Nanobiotechnology in Drug Delivery.

Jain KK.

Methods Mol Biol. 2020;2059:55-73. doi: 10.1007/978-1-4939-9798-5_2.

PMID:
31435915
10.

An Overview of Drug Delivery Systems.

Jain KK.

Methods Mol Biol. 2020;2059:1-54. doi: 10.1007/978-1-4939-9798-5_1.

PMID:
31435914
11.

Brain asymmetry differences between Chinese and Caucasian populations: a surface-based morphometric comparison study.

Lou Y, Zhao L, Yu S, Sun B, Hou Z, Zhang Z, Tang Y, Liu S.

Brain Imaging Behav. 2019 Aug 21. doi: 10.1007/s11682-019-00184-7. [Epub ahead of print]

PMID:
31435899
12.

[Toxic Components of PM2.5 and Their Toxicity Mechanisms-On the Toxicity of Sulfate and Carbon Components].

Sagai M.

Nihon Eiseigaku Zasshi. 2019;74(0). doi: 10.1265/jjh.19004. Japanese.

PMID:
31434811
13.

ADAMDEC1 maintains a growth factor signaling loop in cancer stem cells.

Jimenez-Pascual A, Hale JS, Kordowski A, Pugh J, Silver DJ, Bayik D, Roversi G, Alban TJ, Rao S, Chen R, McIntyre TM, Colombo G, Taraboletti G, Holmberg KO, Forsberg-Nilsson K, Lathia JD, Siebzehnrubl FA.

Cancer Discov. 2019 Aug 21. pii: CD-18-1308. doi: 10.1158/2159-8290.CD-18-1308. [Epub ahead of print]

PMID:
31434712
14.

Syncope as Initial Presentation in an Undifferentiated Type Acute Myeloid Leukemia Patient with Acute Intracranial Hemorrhage.

Wu MY, Lin CH, Hou YT, Lin PC, Yiang GT, Tien YC, Yeh HC.

Brain Sci. 2019 Aug 20;9(8). pii: E207. doi: 10.3390/brainsci9080207.

PMID:
31434194
15.

Driving Neuronal Differentiation through Reversal of an ERK1/2-miR-124-SOX9 Axis Abrogates Glioblastoma Aggressiveness.

Sabelström H, Petri R, Shchors K, Jandial R, Schmidt C, Sacheva R, Masic S, Yuan E, Fenster T, Martinez M, Saxena S, Nicolaides TP, Ilkhanizadeh S, Berger MS, Snyder EY, Weiss WA, Jakobsson J, Persson AI.

Cell Rep. 2019 Aug 20;28(8):2064-2079.e11. doi: 10.1016/j.celrep.2019.07.071.

PMID:
31433983
16.

MSH2 c.1022T>C, p.Leu341Pro is a founder pathogenic variation and a major cause of Lynch syndrome in the North of France.

Vermaut C, Leclerc J, Vasseur F, Wacrenier A, Lovecchio T, Boidin D, Rebergue MH, Cattan S, Manouvrier S, Lejeune S, Buisine MP.

Genes Chromosomes Cancer. 2019 Aug 21. doi: 10.1002/gcc.22804. [Epub ahead of print]

PMID:
31433521
17.

Intracranial Ependymomas: Molecular insights and translation to treatment.

Lester A, McDonald KL.

Brain Pathol. 2019 Aug 21. doi: 10.1111/bpa.12781. [Epub ahead of print] Review.

PMID:
31433520
18.

Systematic Evaluation of Transferrin-Modified Porous Silicon Nanoparticles for Targeted-Delivery of Doxorubicin to Glioblastoma.

Luo M, Lewik G, Ratcliffe JC, Choi CHJ, Mäkilä E, Tong WY, Voelcker NH.

ACS Appl Mater Interfaces. 2019 Aug 21. doi: 10.1021/acsami.9b10787. [Epub ahead of print]

PMID:
31433156
19.

Dutch genome diagnostic laboratories accelerated and improved variant interpretation and increased accuracy by sharing data.

Fokkema IFAC, van der Velde KJ, Slofstra MK, Ruivenkamp CAL, Vogel MJ, Pfundt R, Blok MJ, Lekanne Deprez RH, Waisfisz Q, Abbott KM, Sinke RJ, Rahman R, Nijman IJ, de Koning B, Thijs G, Wieskamp N, Moritz RJG, Charbon B, Saris JJ, den Dunnen JT, Laros JFJ, Swertz MA, van Gijn ME.

Hum Mutat. 2019 Aug 21. doi: 10.1002/humu.23896. [Epub ahead of print]

PMID:
31433103
20.

Upregulation of neurotrophins and transforming growth factor-β expression in the bladder may lead to nerve hyperplasia and fibrosis in patients with severe ketamine-associated cystitis.

Jhang JF, Wang HJ, Hsu YH, Birder LA, Kuo HC.

Neurourol Urodyn. 2019 Aug 21. doi: 10.1002/nau.24139. [Epub ahead of print]

PMID:
31433072

Supplemental Content

Loading ...
Support Center